Both OTX2 and SREBP2 have been implicated in lineage plasticity of prostate tumors and are known regulators of C-MYC34–36, while TFDP1 promotes the proliferation and is frequently upregulated advanced disease37. The gene discussed is OTX2; the disease is prostate neoplasm.